
Hongene Biotech, a contract development and manufacturing organisation (CDMO) and ribonucleic acid (RNA) technology provider, has announced the receipt of …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

